Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 31.25
-0.35 (-1.11%)
Oct 16, 2026, 1:30 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 6.3 billion as of October 16, 2026. It is the 20,985th most valuable company in the world and the 976th biggest in Taiwan. Its market cap has increased by 3.52% in one year.
Market Cap
6.30B
Enterprise Value
7.02B
Revenue
3.45B
Global Rank
Country Rank
#976 Taiwan
PE Ratio
18.00
ChartMarket Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 6.30B, an increase of 459.83%. That is a compound annual growth rate of 7.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 6.30B | 8.61% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEngine | 8.25B |
| Tanvex BioPharma | 8.11B |
| Adimmune | 7.76B |
| Acepodia | 7.70B |
| OBI Pharma | 7.49B |
| Polaris Group | 7.48B |
| Savior Lifetec | 7.23B |
| AnnJi Pharmaceutical | 7.13B |